Abstract
Glial tumors constitute approximately 50% of newly diagnosed primary brain tumors, with low-grade gliomas (LGG) accounting for approximately 15% of all brain tumors in adults [21]. The subset of tumors classified as LGG represents a heterogeneous group of tumors with astrocytic, oligodendroglial, ependymal, or mixed cellular histologies. In the adult population, the term LGG typically refers to the diffuse, infiltrating variety of tumors classified as World Health Organization (WHO) grade II lesions—specifically low-grade astrocytomas, oligodendrogliomas, or mixed oligoastrocytomas [33]. Among low-grade astrocytomas, the most common his-tologic subtypes are the fibrillary, protoplasmic, and gemistocytic variants. There is no indication in the literature that LGGs are more prevalent in a specific ethnic or national group.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bauman G, Lote K, Larson D, et al (1999) Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. Int J Radiat Oncol Biol Phys 45:923–929
Bauman G, Pahapill P, Macdonald D, et al (1999) Low grade glioma: a measuring radiographic response to radiotherapy. The Can J Neurol Sci 26:18–22
Berger MS, Deliganis AV, Dobbins J, et al (1994) The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 74:1784–1791
Bernstein M, Parrent AG. (1994) Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. J Neurosurg 81:165–168
Bloom HJ. (1982) Intracranial tumors: response and resistance to therapeutic endeavors, 1970–1980. Int J Radiat Oncol Biol Phys 8:1083–1113
Bogler O, Huang HJ, Cavenee WK. (1995) Loss of wildtype p53 bestows a growth advantage on primary cortical astrocytes and facilitates their in vitro transformation. Cancer Res 55:2746–2751
Brada M, Viviers L, Abson C, et al (2003) Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol 14:1715–1721
Brown PD, Buckner JC, O'Fallon JR, et al (2004) Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma. Int J Radiat Oncol Biol Phys 59:117–125
Cairncross JG, Ueki K, Zlatescu MC, et al (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90:1473–1479
Cha S, Tihan T, Crawford F, et al (2005) Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 26:266–273
Chang EF, Potts MB, Keles GE, et al (2008) Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg 108:227–235
Chang EF, Smith JS, Chang SM, et al (2008) The UCSF Low Grade Glioma Score: pre-operative prognostic classifi-cation for adult hemispheric low grade gliomas. Journal of Neurosurgery 109:817–824
Claus EB, Horlacher A, Hsu L, et al (2005) Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer 103:1227–1233
Cunningham JM, Kimmel DW, Scheithauer BW, et al (1997) Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value. J Neurosurg 86:121–130
Davis FG, Malinski N, Haenszel W, et al (1996) Primary brain tumor incidence rates in four United States regions, 1985–1989: a pilot study. Neuroepidemiology 15:103–112
Di Costanzo A, Scarabino T, Trojsi F, et al (2006) Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy. Neuroradiology 48:622–631
Di Costanzo A, Trojsi F, Giannatempo GM, et al (2006) Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 Tesla in the delineation of glioblastomas: preliminary results. J Exp Clin Cancer Res 25:383–390
Eyre HJ, Crowley JJ, Townsend JJ, et al (1993) A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: a Southwest Oncology Group study. J Neurosurg 78:909–914
Fisher PG, Breiter SN, Carson BS, et al (2000) A clinico-pathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astro-cytoma as distinct entities. Cancer 89:1569–1576
Franzini A, Leocata F, Cajola L, et al (1994) Low-grade glial tumors in basal ganglia and thalamus: natural history and biological reappraisal. Neurosurgery 35:817–820; discussion 820–811
Guthrie BL, Laws ER, Jr. (1990) Supratentorial low-grade gliomas. Neurosurg Clin N Am 1:37–48
Hakyemez B, Erdogan C, Ercan I, et al (2005) High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Clin Radiol 60:493–502
Hammoud MA, Ligon BL, elSouki R, et al (1996) Use of intraoperative ultrasound for localizing tumors and determining the extent of resection: a comparative study with magnetic resonance imaging. J Neurosurg 84:737–741
Hanzely Z, Polgar C, Fodor J, et al (2003) Role of early radiotherapy in the treatment of supratentorial WHO Grade II astrocytomas: long-term results of 97 patients. J Neurooncol 63:305–312
Hoang-Xuan K, Capelle L, Kujas M, et al (2004) Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 22:3133–3138
Ito S, Chandler KL, Prados MD, et al (1994) Proliferative potential and prognostic evaluation of low-grade astrocy-tomas. J Neurooncol 19:1–9
James CD, Carlbom E, Nordenskjold M, et al (1989) Mitotic recombination of chromosome 17 in astrocytomas. Proc Natl Acad Sci USA 86:2858–2862
Janny P, Cure H, Mohr M, et al (1994) Low grade supraten-torial astrocytomas. Management and prognostic factors. Cancer 73:1937–1945
Jeremic B, Grujicic D, Antunovic V, et al (1994) Hyper-fractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study. Int J Radiat Oncol Biol Phys 30:1179–1185
Jeun SS, Kim MC, Kim BS, et al (2005) Assessment of malignancy in gliomas by 3T 1H MR spectroscopy. Clin Imaging 29:10–15
Johannesen TB, Langmark F, Lote K. (2003) Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a population-based study of 993 patients in whom tumors were diagnosed between 1970 and 1993. J Neurosurg 99:854–862
Karim AB, Maat B, Hatlevoll R, et al (1996) A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 36:549–556
Kleihues P, Cavenee WK. (2000) Pathology and genetics of tumours of the nervous system. IARC Press, Lyon
Laack NN, Brown PD, Ivnik RJ, et al (2005) Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study. Int J Radiat Oncol Biol Phys 63:1175–1183
Laws ER, Jr., Taylor WF, Bergstralh EJ, et al (1986) The neurosurgical management of low-grade astrocytoma. Clin Neurosurg 33:575–588
Leighton C, Fisher B, Bauman G, et al (1997) Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncology 15:1294–1301
Levin N, Lavon I, Zelikovitsh B, et al (2006) Progressive low-grade oligodendrogliomas: response to temozolomide and cor- relation between genetic profile and O6-methylguanine DNA methyltransferase protein expression. Cancer 106:1759–1765
Lote K, Egeland T, Hager B, et al (1997) Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol 15:3129–3140
Lunsford LD, Somaza S, Kondziolka D, et al (1995) Brain astrocytomas: biopsy, then irradiation. Clin Neurosurg 42:464–479
Lunsford LD, Somaza S, Kondziolka D, et al (1995) Survival after stereotactic biopsy and irradiation of cerebral nonana-plastic, nonpilocytic astrocytoma. J Neurosurg 82:523–529
Magalhaes A, Godfrey W, Shen Y, et al (2005) Proton magnetic resonance spectroscopy of brain tumors correlated with pathology. Acad Radiol 12:51–57
McCormack BM, Miller DC, Budzilovich GN, et al (1992) Treatment and survival of low-grade astrocytoma in adults — 1977–1988. Neurosurgery 31:636–642; discussion 642
McKnight TR, Lamborn KR, Love TD, et al (2007) Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas. J Neurosurg 106:660–666
Minn H. (2005) PET and SPECT in low-grade glioma. Eur J Radiol 56:171–178
Muller W, Afra D, Schroder R. (1977) Supratentorial recurrences of gliomas. Morphological studies in relation to time intervals with astrocytomas. Acta Neurochir (Wien) 37:75–91
Nakamura M, Konishi N, Tsunoda S, et al (2000) Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults. Oncology 58:108–116
Nakamura T, Hirato J, Hotchi M, et al (1990) Astrocytoma with granular cell tumor-like changes. Report of a case with histochemical and ultrastructural characterization of granular cells. Acta Pathol Jpn 40:206–211
Nicolato A, Gerosa MA, Fina P, et al (1995) Prognostic factors in low-grade supratentorial astrocytomas: a uni-multivariate statistical analysis in 76 surgically treated adult patients. Surgical neurology 44:208–221; discussion 221–203
North CA, North RB, Epstein JA, et al (1990) Low-grade cerebral astrocytomas. Survival and quality of life after radiation therapy. Cancer 66:6–14
Peraud A, Ansari H, Bise K, et al (1998) Clinical outcome of supratentorial astrocytoma WHO grade II. Acta Neuro-chirurgica 140:1213–1222
Perry A, Jenkins RB, O'Fallon JR, et al (1999) Clinico-pathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expression. Cancer 86:672–683
Philippon JH, Clemenceau SH, Fauchon FH, et al (1993) Supratentorial low-grade astrocytomas in adults. Neurosurgery 32:554–559
Piepmeier J, Christopher S, Spencer D, et al (1996) Variations in the natural history and survival of patients with supratento-rial low-grade astrocytomas. Neurosurgery 38:872–878; discussion 878–879
Piepmeier JM. (1987) Observations on the current treatment of low-grade astrocytic tumors of the cerebral hemispheres. J Neurosurg 67:177–181
Pignatti F, van den Bent M, Curran D, et al (2002) Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20:2076–2084
Pouratian N, Gasco J, Sherman JH, et al (2007) Toxicity and efficacy of protracted low dose temozolomide for the treatment of low grade gliomas. J Neurooncol 82:281–288
Practice parameters in adults with suspected or known supratentorial nonoptic pathway low-grade glioma. (1998) Neurosurg Focus 4:e10
Price SJ, Jena R, Burnet NG, et al (2006) Improved delineation of glioma margins and regions of infiltration with the use of diffusion tensor imaging: an image-guided biopsy study. AJNR Am J Neuroradiol 27:1969–1974
Price SJ, Pena A, Burnet NG, et al (2004) Detecting glioma invasion of the corpus callosum using diffusion tensor imaging. Br J Neurosurg 18:391–395
Rajan B, Pickuth D, Ashley S, et al (1994) The management of histologically unverified presumed cerebral gliomas with radiotherapy. Int J Radiat Oncol Biol Phys 28:405–413
Recht LD, Lew R, Smith TW. (1992) Suspected low-grade glioma: is deferring treatment safe? Ann Neurol 31:431–436
Reifenberger J, Reifenberger G, Liu L, et al (1994) Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 145:1175–1190
Rey JA, Bello MJ. (1999) Cytogenetics. In: Berger MS, Wilsons CW (eds) The gliomas. W.B. Saunders, Philadelphia, PA, pp. 25–37
Sanai N, Alvarez-Buylla A, Berger MS. (2005) Neural stem cells and the origin of gliomas. N Engl J Med 353:811–822
Sanai N, Berger MS. (2008) Glioma extent of resection and its impact on patient outcome. Neurosurgery 62:753–764; discussion 264–756
Sanai N, Mirzadeh Z, Berger MS. (2008) Functional outcome after language mapping for glioma resection. N Engl J Med 358:18–27
Scerrati M, Roselli R, Iacoangeli M, et al (1996) Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery. J Neurol Neurosurg Psychiatry 61:291–296
Schiff D. (2007) Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation. Cancer Invest 25:776–784
Schiffer D, Cavalla P, Chio A, et al (1997) Proliferative activity and prognosis of low-grade astrocytomas. J Neurooncol 34:31–35
Shafqat S, Hedley-Whyte ET, Henson JW. (1999) Age-dependent rate of anaplastic transformation in low-grade astrocytoma. Neurology 52:867–869
Shaw E, Arusell R, Scheithauer B, et al (2002) Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 20:2267–2276
Shibamoto Y, Kitakabu Y, Takahashi M, et al (1993) Supratentorial low-grade astrocytoma. Correlation of computed tomography findings with effect of radiation therapy and prognostic variables. Cancer 72:190–195
Shimizu H, Kumabe T, Tominaga T, et al (1996) Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. AJNR Am J Neuroradiol 17:737–747
Smith JS, Chang EF, Lamborn KR, et al (2008) Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26:1338–1345
Soffietti R, Chio A, Giordana MT, et al (1989) Prognostic factors in well-differentiated cerebral astrocytomas in the adult. Neurosurgery 24:686–692
Szymanski MD, Rowley HA, Roberts TP. (1999) A hemi-spherically asymmetrical MEG response to vowels. Neuroreport 10:2481–2486
Taphoorn MJ, Schiphorst AK, Snoek FJ, et al (1994) Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol 36:48–54
Tihan T, Davis R, Elowitz E, et al (2000) Practical value of Ki-67 and p53 labeling indexes in stereotactic biopsies of diffuse and pilocytic astrocytomas. Arch Pathol Lab Med 124:108–113
van den Bent MJ, Afra D, de Witte O, et al (2005) Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 366:985–990
van Veelen ML, Avezaat CJ, Kros JM, et al (1998) Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry 64:581–587
Vertosick FT, Jr., Selker RG, Arena VC. (1991) Survival of patients with well-differentiated astrocytomas diagnosed in the era of computed tomography. Neurosurgery 28:496–501
Watanabe K, Sato K, Biernat W, et al (1997) Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Clin Cancer Res 3:523–530
Whitton AC, Bloom HJ. (1990) Low grade glioma of the cerebral hemispheres in adults: a retrospective analysis of 88 cases. Int J Radiat Oncol Biol Phys 18:783–786
Woodworth GF, McGirt MJ, Samdani A, et al (2006) Frameless image-guided stereotactic brain biopsy procedure: diagnostic yield, surgical morbidity, and comparison with the frame-based technique. J Neurosurg 104:233–237
Yahanda AM, Bruner JM, Donehower LA, et al (1995) Astrocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomas. Mol Cell Biol 15:4249–4259
Yeh SA, Ho JT, Lui CC, et al (2005) Treatment outcomes and prognostic factors in patients with supratentorial low-grade gliomas. Br J Radiol 78:230–235
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sanai, N., Berger, M.S. (2010). Low-Grade Astrocytomas. In: Tonn, JC., Westphal, M., Rutka, J.T. (eds) Oncology of CNS Tumors. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02874-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-02874-8_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-02873-1
Online ISBN: 978-3-642-02874-8
eBook Packages: MedicineMedicine (R0)